| Nicoli, Francesco, Papagno, Laura, Frere, Justin J., Cabral-Piccin, Mariela Pires, Clave, Emmanuel, Gostick, Emma, Toubert, Antoine, Price, David A.  ORCID: https://orcid.org/0000-0001-9416-2737, Caputo, Antonella and Appay, Victor
      2018.
      
      Naïve CD8+ T-cells engage a versatile metabolic program upon activation in humans and differ energetically from memory CD8+ T-cells.
      Frontiers in Immunology
      9
      
      , -.
      
      10.3389/fimmu.2018.02736   | 
| Preview | PDF
 - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview | 
Abstract
Background: Characterization of the intracellular biochemical processes that regulate the generation and maintenance of effector and memory CD8+ T-cells from naïve precursors is essential for our understanding of adaptive immune responses and the development of immunotherapies. However, the metabolic determinants of antigen-driven activation and differentiation remain poorly defined, especially in humans. Methods: We used a variety of different approaches, including gene expression profiling and measurements of nutrient flux, to characterize the basal and activation-induced energetic requirements of naïve and phenotypically-defined subsets of human memory CD8+ T-cells. Findings: Profound metabolic differences were apparent as a function of differentiation status, both at rest and in response to stimulation via the T cell receptor (TCR). Of particular note, resting naïve CD8+ T cells were largely quiescent, but rapidly upregulated diverse energetic pathways after ligation of surface-expressed TCRs. Moreover, autophagy and the mechanistic target of rapamycin (mTOR)-dependent glycolytic pathway were identified as critical mediators of antigen-driven priming in the naïve CD8+ T cell pool, the efficiency of which was dampened by the presence of neutral lipids and fatty acids. Interpretation: These observations provide a metabolic roadmap of the CD8+ T-cell compartment in humans and reveal potentially selective targets for novel immunotherapies.
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Medicine | 
| Publisher: | Frontiers Media | 
| ISSN: | 1664-3224 | 
| Date of First Compliant Deposit: | 22 January 2019 | 
| Date of Acceptance: | 6 November 2018 | 
| Last Modified: | 03 May 2023 16:47 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/118588 | 
Citation Data
Cited 25 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
|  | Edit Item | 

 
							

 Altmetric
 Altmetric Altmetric
 Altmetric